Green Thumb Industries (GTBIF) Cash from Financing Activities (2019 - 2026)
Green Thumb Industries (GTBIF) reported Cash from Financing Activities of $5.7 million for Q1 2026, up 219.97% on a YoY basis from $1.8 million in Q1 2025, and up 127.02% quarter-over-quarter from -$21.1 million in Q4 2025.
Green Thumb Industries (GTBIF) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Cash from Financing Activities for 8 years, with the latest figure at $5.7 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 219.97% year-over-year to $5.7 million; the trailing twelve-month figure through Mar 2026 stood at -$40.5 million (up 54.46% YoY), and the FY2025 full-year result was -$50.9 million, up 46.71% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $5.7 million, up from -$21.1 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $18.9 million in Q4 2022, with the low at -$51.1 million in Q3 2024.
- Historically, Cash from Financing Activities has averaged -$8.5 million across 5 years, with a median of -$5.8 million in 2023.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities soared 10420.0% — and 2024, when it slumped 8320.59%.
- Green Thumb Industries' Cash from Financing Activities stood at $18.9 million in 2022, then plunged by 130.97% to -$5.8 million in 2023, then tumbled by 57.38% to -$9.2 million in 2024, then plunged by 129.8% to -$21.1 million in 2025, then surged by 127.02% to $5.7 million in 2026.
- The last three Cash from Financing Activities figures came in at $5.7 million (Q1 2026), -$21.1 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -11.62 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -77.88 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | 5.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.71 Mn |
| Mar 31, 2026 | 5.71 Mn |
| Dec 31, 2025 | -21.12 Mn |
| Dec 31, 2025 | -21.12 Mn |
| Sep 30, 2025 | -2.63 Mn |
| Sep 30, 2025 | -2.63 Mn |
| Jun 30, 2025 | -22.43 Mn |
| Jun 30, 2025 | -22.43 Mn |
| Mar 31, 2025 | -4.76 Mn |
| Mar 31, 2025 | -4.76 Mn |
| Dec 31, 2024 | -9.19 Mn |
| Dec 31, 2024 | -9.19 Mn |
| Sep 30, 2024 | -51.06 Mn |
| Sep 30, 2024 | -51.06 Mn |
| Jun 30, 2024 | -23.89 Mn |
| Jun 30, 2024 | -23.89 Mn |
| Mar 31, 2024 | -11.45 Mn |
| Mar 31, 2024 | -11.45 Mn |
| Dec 31, 2023 | -5.84 Mn |
| Dec 31, 2023 | -5.84 Mn |